BAXTER HEALTHCARE CORPORATION

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Hemopatch Compared to TachoSil in Postoperative Air Leak Duration After Pulmonary Resection

Not Applicable

Completed

Conditions: Air Leak From Lung

Interventions: Device: Hemopatch
Device: Tachosil

First Posted Date: 2018-03-01

Last Posted Date: 2020-04-06

Lead Sponsor: Baxter Healthcare Corporation

Target Recruit Count: 279

Registration Number: NCT03450265

Locations: 🇪🇸
Baxter Investigational Site, Madrid, Spain

Hemopatch Performance Evaluation: A Prospective Observational Registry

Completed

Conditions: Dura Mater Nick Cut or Tear
Hemostatis
Air Leakage
Body Fluid Leakage

Interventions: Device: Hemopatch

First Posted Date: 2018-01-08

Last Posted Date: 2022-11-16

Lead Sponsor: Baxter Healthcare Corporation

Target Recruit Count: 621

Registration Number: NCT03392662

Locations: 🇦🇹
Innsbruck Universitaetsklinik, Innsbruck, Austria
🇨🇿
Fakultní nemocnice u sv. Anny v Brně, Brno, Czechia
🇨🇿
Krajská Nemocnice Liberec, Liberec, Czechia

and more 12 locations

Theranova 400 Dialyzer In End Stage Renal Disease (ESRD) Patients

Not Applicable

Completed

Conditions: End Stage Renal Disease

Interventions: Device: Theranova 400 dialyzer
Device: Elisio-17H dialyzer

First Posted Date: 2017-08-22

Last Posted Date: 2021-01-06

Lead Sponsor: Baxter Healthcare Corporation

Target Recruit Count: 172

Registration Number: NCT03257410

Locations: 🇺🇸
DaVita Five Star Dialysis Center, Las Vegas, Nevada, United States
🇺🇸
DaVita Inc., Medical Center Dialysis, Houston, Texas, United States
🇺🇸
DaVita Inc., South Las Vegas Dialysis, Las Vegas, Nevada, United States

and more 17 locations

Remotely Monitoring Patients With Chronic Conditions in Their Home

Completed

Conditions: CHF

Interventions: Device: Discontinuation of using device

First Posted Date: 2017-07-05

Last Posted Date: 2019-09-10

Lead Sponsor: Baxter Healthcare Corporation

Target Recruit Count: 36

Registration Number: NCT03207802

Locations: 🇺🇸
Elite Home Health, Texarkana, Arkansas, United States

Efficacy and Safety of FS VH S/D 500 S-apr (Tisseel) as an Adjunct to Sutured Dural Repair in Cranial Surgery

Phase 3

Completed

Conditions: Cerebrospinal Fluid Leak

Interventions: Device: DuraSeal Dural Sealant
Drug: FS VH S/D 500 s-apr

First Posted Date: 2016-09-07

Last Posted Date: 2019-09-10

Lead Sponsor: Baxter Healthcare Corporation

Target Recruit Count: 224

Registration Number: NCT02891070

Locations: 🇺🇸
University Hospitals Case Medical Center, Cleveland, Ohio, United States
🇪🇸
University Hospital 12 de Octubre, Madrid, Spain
🇪🇸
Hospital Clinic I Provincial de Barcelona, Barcelona, Spain

and more 22 locations

Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)

Phase 3

Terminated

Conditions: Regional Citrate Anticoagulation (RCA)
Continuous Renal Replacement Therapy (CRRT)
Acute Kidney Injury

Interventions: Drug: Prismocitrate 18
Other: No Anticoagulation

First Posted Date: 2016-08-09

Last Posted Date: 2021-01-05

Lead Sponsor: Baxter Healthcare Corporation

Target Recruit Count: 34

Registration Number: NCT02860130

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
University of Mississippi Medical Center, Jackson, Mississippi, United States

and more 9 locations

Automated Setting of Individualized Sodium Technology

Not Applicable

Completed

Conditions: End Stage Renal Disease (ESRD)

Interventions: Device: Artis Haemodialysis Machine w/ ASIST Software - Isonatremic
Device: Artis Haemodialysis Machine w/ ASIST Software - Isotonic
Device: Artis Haemodialysis Machine w/o ASIST Software

First Posted Date: 2016-06-10

Last Posted Date: 2017-04-20

Lead Sponsor: Baxter Healthcare Corporation

Target Recruit Count: 18

Registration Number: NCT02795286

Locations: 🇸🇪
Skane University Hospital, Malmö, Skane, Sweden

Necklace-Shaped Sensor for Non-Invasive Monitoring of Stroke Volume and Cardiac Output

Completed

Conditions: Heart Failure

First Posted Date: 2016-03-25

Last Posted Date: 2017-07-02

Lead Sponsor: Baxter Healthcare Corporation

Target Recruit Count: 85

Registration Number: NCT02719301

Effectiveness and Safety of CELSTAT for Hemostasis in Intraoperative Tissue Bleeding

Not Applicable

Completed

Conditions: Bleeding Active

Interventions: Device: CELSTAT
Device: Surgicel Original

First Posted Date: 2015-12-28

Last Posted Date: 2020-08-03

Lead Sponsor: Baxter Healthcare Corporation

Target Recruit Count: 260

Registration Number: NCT02640235

Locations: 🇺🇸
Infectious Disease of Indiana, PSC, Carmel, Indiana, United States
🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
🇵🇱
Non-Public Specialist Healthcare Facility "MEDICUS", Sroda Wielkopolska, Poland

and more 22 locations

Prismaflex HF20 Set and Prismaflex® System 7.10/7.20 for Acute Continuous Renal Replacement Therapy (CRRT) in Children

Not Applicable

Terminated

Conditions: Acute Kidney Injury in Pediatric Patients

Interventions: Device: Prismaflex HF20 CRRT Filter
Device: Prismaflex® System 7.10 and 7.20

First Posted Date: 2015-09-28

Last Posted Date: 2021-06-25

Lead Sponsor: Baxter Healthcare Corporation

Target Recruit Count: 23

Registration Number: NCT02561247

Locations: 🇺🇸
University of Iowa Children's Hospital, Iowa City, Iowa, United States
🇺🇸
Lucile Packard Children's Hospital Stanford, Stanford, California, United States
🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

and more 3 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy